FORESITE 360
Dead · Withdrawn DEAD/APPLICATION/Withdrawn/Abandoned
What this record means
The record shows that the mark “FORESITE 360” is dead, having been abandoned by its owner, Fore Genomics, Inc., a Delaware corporation. The mark was filed as a service mark on March 20, 2023 under the intent‑to‑use basis and was registered on the Principal Register. It covers a wide range of genetic testing and analysis services, including whole‑genome sequencing for medical, health, and diagnostic purposes, as well as subscription services for genetic screening across all life stages. A similar name would raise the closest concern in the same medical and diagnostic testing field. The record does not give the owner control over every use of the wording, only over the specific services listed. The latest event is the express abandonment mailed on March 12, 2024, with no further maintenance or enforcement actions recorded. For someone considering a similar name, the abandoned status reduces the risk, but the specific medical testing services remain a potential point of concern.
Informational only - not legal advice.Mark Service Mark
| Drawing type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S) |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because the applicant filed an express abandonment. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Mar 20, 2023 |
| Status date | Mar 12, 2024 |
Goods & services
Genetic testing and analysis services for medical, health, and diagnostic purposes; Whole genome sequence screening for medical, health, and diagnostic purposes; Whole genome sequence screening for purposes of disease, medication, and health risk screening; Whole genome sequence screening for medical, health, and diagnostic purposes in humans; Whole genome sequence screening for medical, health, and diagnostic purposes in newborns, infants, children, and adolescents; Whole genome sequence screening for medical, health, and diagnostic purposes from infancy to adulthood; Subscription services for genetic screening during early stages of life; Subscription services for genetic screening in newborns, infants, children, and adolescents; Subscription services for genetic screening from infancy to adulthood; Subscription services for genetic testing that includes routine reanalysis of a subscriber's genomic profile to provide updates on genetic conditions and potential new treatments; Genetic screening and counseling services in the fields of genetics, health, and medication counseling; Genetic counseling; Clinical genetic screening of whole genome in early stages of life to identify genetic conditions and actionable treatment plans; Provision of online patient portal for ordering genetic tests and accessing genetic information and testing results
Owner & representation
| Owner | Fore Genomics, Inc. |
| Address | # 600, 4225 Executive Square, La Jolla, CALIFORNIA UNITED STATES 92037 |
| Entity | CORPORATION - organized in DELAWARE |
| Attorney of record | James DeZazzo |
| Correspondent | James DeZazzo |
| Attorney email | j********@*****.com |
| Correspondent email | 4 emails |
| Correspondent phone | 7********5 |
| Correspondent address | VOORHEES, NEW |